| |||||||||
| Mice homozygous for this targeted allele (Nf123a-/-) lack the alternatively spliced exon 23a (which modifies the GTPase-activating protein (GAP) domain of Nf1). These mutant mice may be useful for neurological studies of Neurofibromatosis Type I, growth, differentiation, and learning and memory. | |||||||||
Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Donating Investigator Alcino Silva, University of California, Los Angeles Description
Mice homozygous for this targeted allele (Nf123a-/-) lack the alternatively spliced exon 23a (which modifies the GTPase-activating protein (GAP) domain of Nf1), and are viable and fertile. Protein and mRNA isolated from homozygous brain tissue shows normal type I (exon 1-21 containing) neurofibromin isoform but absence of the alternatively spliced, exon 23a-containing type II neurofibromin isoform (which has a greater affinity for Ras but lower GAP activity than the type I isoform). Homozygotes have no reported increase in tumor predisposition, but show specific learning impairments in contextual discrimination, spatial learning, and coordination. These Nf123a-/- mutant mice may be useful for neurological studies of Neurofibromatosis Type I, growth, differentiation, and learning and memory.Development
A targeting vector was designed to replace 300 bp (including exon 23a) of the targeted gene with a neo cassette. The construct was electroporated into 129S1/Sv-derived CJ7 embryonic stem (ES) cells. Correctly targeted ES cells were injected into blastocysts. The resulting chimeric males were bred with C57BL/6J females. These resulting Nf123a- mutant mice were then backcrossed to C57BL/6NTac for at least seven generations prior to arrival at The Jackson Laboratory.
| Control | ||
|---|---|---|
| 000664 C57BL/6J | (approximate) | |
| 005304 C57BL/6NJ | (approximate) | |
| Considerations for Choosing Controls | ||
Strains carrying other alleles of Nf1
002646 B6.129S6-Nf1tm1Fcr/J 008191 B6;129S2-Trp53tm1Tyj Nf1tm1Tyj/J View Strains carrying other alleles of Nf1 (2 strains)
Congenic Nomenclature
View Related Disease (OMIM) Terms
Related Disease (OMIM) Terms
Neurofibromatosis, Type I; NF1 - Models with phenotypic similarity to human disease where etiologies involve orthologs.1
1 Human genes are associated with this disease. Orthologs of those genes appear in the mouse genotype(s).
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Nf1tm1Cbr/Nf1+
involves: 129S1/Sv * C57BL/6
- tumorigenesis
- *normal* tumorigenesis (MGI Ref ID J:68489)
- mice do not have an increase in predisposition for tumor formation
Nf1tm1Cbr/Nf1tm1Cbr
involves: 129S1/Sv * C57BL/6
- behavior/neurological phenotype
- abnormal discrimination learning (MGI Ref ID J:68489)
- mice exhibit impaired contextual discrimination; during first two days of training, mutants do not discriminate between a chamber in which they receive a mild shock and a chamber in which they do not, however after 3 days of training, begin to discriminate between the chambers
- abnormal spatial learning (MGI Ref ID J:68489)
- in a probe trial, mutants search randomly rather than selectively, and spend significantly less time searching for the platform in the training quadrant than wild-type
- additional training alleviates the learning deficits
- impaired coordination (MGI Ref ID J:68489)
- mice fall off a rotating rod sooner than wild-type, however swimming speed, ambulance, exploratory behavior, and muscular strength are normal
- tumorigenesis
- *normal* tumorigenesis (MGI Ref ID J:68489)
- mice do not have an increase in predisposition for tumor formation
- nervous system phenotype
- *normal* nervous system phenotype (MGI Ref ID J:68489)
- mice do not exhibit gross or microscopic abnormalities in the brain, including no astrogliosis
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Mouse/Human Gene Homologs
Neurofibromatosis Type I
Neurobiology Research
Behavioral and Learning Defects
Research Tools
Neurobiology Research
| Allele Symbol | Nf1tm1Cbr | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Camilyn Brannan | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | Nf123a-/-; | ||
| Mutation Made By | Alcino Silva, University of California, Los Angeles | ||
| Strain of Origin | 129S1/Sv-Oca2<+> Tyr<+> Kitl<+> | ||
| ES Cell Line Name | CJ7 | ||
| ES Cell Line Strain | 129S1/Sv-Oca2<+> Tyr<+> Kitl<+> | ||
| Gene Symbol and Name | Nf1, neurofibromatosis 1 | ||
| Chromosome | 11 | ||
| Gene Common Name(s) | AW494271; DKFZp686J1293; FLJ21220; NFNS; Nf-1; VRNF; WSS; expressed sequence AW494271; neurofibromin; | ||
| Molecular Note | Insertion of a neomycin resistance cassette replaced 300 bp of genomic DNA including exon 23a. RT-PCR analysis of brain detected neurofibromin type I but not the type II isoform in homozygous mutant mice. Western blot analysis detected the type I but notthe type II neurofibronin in brain of homozygous mutant mice. Immunohistochemical analysis of brain did not detect type II neurofibromin isoform in homozygous mutant mice. [MGI Ref ID J:68489] | ||
Genotyping Protocols
Nf1tm1Cbr, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Costa RM; Yang T; Huynh DP; Pulst SM; Viskochil DH; Silva AJ; Brannan CI. 2001. Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nat Genet 27(4):399-405. [PubMed: 11279521] [MGI Ref ID J:68489]
Nf1tm1Cbr relatedDevon RS. 2001. Clin Genet 60:99-103. [MGI Ref ID J:71298]
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, homozygous mice may be bred.
This strain is currently Under Development for Distribution Colony.
To register your interest in this strain go to the Strain Interest Form.
Estimated Available for Sale Date:
Please note: Estimated available for sale dates are provided to keep customers better informed on strains under development. Please note that our Colony Managers routinely monitor the target date and edit it based on breeding performance and other factors. The length of time it takes to make a new strain available for sale depends on genotype, age, number of animals sent by the Donating Investigator, breeding performance, additional strain development (backcrossing, making homozygous), and anticipated demand for the strain/interest registered.
View All Strains Under Development and On Hold
| Standard Supply | Under Development for Distribution Colony |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| 000664 C57BL/6J | (approximate) | |
| 005304 C57BL/6NJ | (approximate) | |
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.